Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 91.7 HKD -6.24% Market Closed
Updated: May 24, 2024

Beigene Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beigene Ltd
Gross Profit Peer Comparison

Comparables:
1801
603392
B
600161
300122
300896

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Beigene Ltd
HKEX:6160
Gross Profit
¥14.7B
CAGR 3-Years
108%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Gross Profit
¥5.1B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Gross Profit
¥4.5B
CAGR 3-Years
34%
CAGR 5-Years
45%
CAGR 10-Years
N/A
B
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Gross Profit
¥2.7B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
10%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Gross Profit
¥13.6B
CAGR 3-Years
28%
CAGR 5-Years
33%
CAGR 10-Years
40%
Imeik Technology Development Co Ltd
SZSE:300896
Gross Profit
¥1.8B
CAGR 3-Years
53%
CAGR 5-Years
57%
CAGR 10-Years
N/A

See Also

What is Beigene Ltd's Gross Profit?
Gross Profit
14.7B CNY

Based on the financial report for Dec 31, 2023, Beigene Ltd's Gross Profit amounts to 14.7B CNY.

What is Beigene Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
67%

Over the last year, the Gross Profit growth was 92%. The average annual Gross Profit growth rates for Beigene Ltd have been 108% over the past three years , 67% over the past five years .